Cormorant Asset Management as of Sept. 30, 2018
Portfolio Holdings for Cormorant Asset Management
Cormorant Asset Management holds 61 positions in its portfolio as reported in the September 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Nektar Therapeutics (NKTR) | 10.7 | $165M | 2.7M | 60.96 | |
| Anaptysbio Inc Common (ANAB) | 7.4 | $113M | 1.1M | 99.77 | |
| Mirati Therapeutics | 5.5 | $85M | 1.8M | 47.10 | |
| Avrobio Ord (AVRO) | 5.0 | $77M | 1.5M | 51.87 | |
| Apellis Pharmaceuticals (APLS) | 4.8 | $74M | 4.2M | 17.78 | |
| Tesaro | 4.4 | $68M | 1.8M | 39.01 | |
| Dicerna Pharmaceuticals | 3.5 | $54M | 3.6M | 15.26 | |
| Reata Pharmaceuticals Inc Cl A | 3.5 | $54M | 660k | 81.76 | |
| Omeros Corporation (OMER) | 3.4 | $52M | 2.1M | 24.41 | |
| Inflarx Nv (IFRX) | 3.0 | $46M | 1.3M | 34.32 | |
| Myokardia | 3.0 | $46M | 700k | 65.20 | |
| Principia Biopharma | 2.8 | $43M | 1.5M | 29.22 | |
| Autolus Therapeutics Plc spon ads (AUTL) | 2.6 | $41M | 1.3M | 30.67 | |
| Zogenix | 2.4 | $37M | 750k | 49.60 | |
| Rocket Pharmaceuticals (RCKT) | 2.4 | $37M | 1.5M | 24.62 | |
| Quotient | 2.4 | $37M | 4.9M | 7.55 | |
| Theravance Biopharma (TBPH) | 2.3 | $36M | 1.1M | 32.67 | |
| G1 Therapeutics | 2.2 | $34M | 641k | 52.29 | |
| Kezar Life Sciences (KZR) | 2.2 | $33M | 1.6M | 21.41 | |
| Solid Biosciences | 2.1 | $32M | 671k | 47.18 | |
| Blueprint Medicines (BPMC) | 1.9 | $30M | 380k | 78.06 | |
| Sage Therapeutics (SAGE) | 1.7 | $27M | 190k | 141.25 | |
| Ascendis Pharma A S (ASND) | 1.6 | $25M | 350k | 70.86 | |
| Tricida | 1.5 | $22M | 735k | 30.55 | |
| Neurocrine Biosciences (NBIX) | 1.4 | $22M | 175k | 122.95 | |
| Kiniksa Pharmaceuticals | 1.4 | $21M | 831k | 25.50 | |
| Arena Pharmaceuticals | 1.2 | $19M | 410k | 46.02 | |
| Incyte Corporation (INCY) | 1.2 | $18M | 260k | 69.08 | |
| Zai Lab (ZLAB) | 1.0 | $16M | 808k | 19.48 | |
| Argenx Se (ARGX) | 0.9 | $14M | 190k | 75.84 | |
| Inspire Med Sys (INSP) | 0.8 | $13M | 300k | 42.08 | |
| Biohaven Pharmaceutical Holding | 0.6 | $9.8M | 260k | 37.55 | |
| Array BioPharma | 0.6 | $9.1M | 600k | 15.20 | |
| Rubius Therapeutics | 0.6 | $8.7M | 365k | 24.00 | |
| Constellation Pharmceticls I | 0.6 | $8.6M | 1.3M | 6.73 | |
| Spectrum Pharmaceuticals | 0.6 | $8.4M | 500k | 16.80 | |
| Amarin Corporation (AMRN) | 0.5 | $8.1M | 500k | 16.27 | |
| Minerva Neurosciences | 0.5 | $7.6M | 608k | 12.55 | |
| Replimune Group (REPL) | 0.5 | $7.5M | 468k | 16.10 | |
| Aclaris Therapeutics (ACRS) | 0.5 | $7.3M | 500k | 14.52 | |
| Abeona Therapeutics | 0.4 | $6.4M | 500k | 12.80 | |
| Contrafect | 0.4 | $6.2M | 3.0M | 2.07 | |
| Heron Therapeutics (HRTX) | 0.3 | $5.4M | 170k | 31.65 | |
| Scholar Rock Hldg Corp (SRRK) | 0.3 | $5.4M | 210k | 25.75 | |
| Y Mabs Therapeutics (YMAB) | 0.3 | $5.3M | 200k | 26.56 | |
| Audentes Therapeutics | 0.3 | $4.9M | 125k | 39.59 | |
| Translate Bio | 0.3 | $4.5M | 455k | 10.00 | |
| Eidos Therapeutics | 0.2 | $3.9M | 386k | 9.98 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 0.2 | $3.7M | 250k | 14.74 | |
| Akcea Therapeutics Inc equities | 0.2 | $3.5M | 100k | 35.02 | |
| Sangamo Biosciences (SGMO) | 0.2 | $3.4M | 200k | 16.95 | |
| Meiragtx Holdings (MGTX) | 0.2 | $3.2M | 239k | 13.60 | |
| Iterum Therapeutics | 0.2 | $3.2M | 477k | 6.70 | |
| Acceleron Pharma | 0.2 | $2.9M | 50k | 57.24 | |
| Marinus Pharmaceuticals | 0.2 | $3.0M | 300k | 10.00 | |
| Trillium Therapeutics, Inc. Cmn | 0.2 | $2.9M | 500k | 5.80 | |
| Clearside Biomedical (CLSD) | 0.2 | $2.5M | 400k | 6.15 | |
| ArQule | 0.1 | $1.7M | 300k | 5.66 | |
| Quanterix Ord (QTRX) | 0.1 | $1.2M | 55k | 21.42 | |
| Cellectar Biosciences Equity Warrants *w | 0.0 | $4.2k | 53k | 0.08 | |
| Oncobiologics Inc *w exp 02/18/201 | 0.0 | $8.3k | 417k | 0.02 |
